A new sales license gave a lift to a Canadian cannabis stock Monday. Here’s some small stocks making big moves on Monday, June 1, 2020 (as of 4 pm EST):
HEXO Corp. (TSX:HEXO), a Canadian cannabis stock, gained 9% to $0.93 on Monday after announcing that its Belleville, Ontario manufacturing and processing facility has received a Health Canada license amendment for the sale of dried and fresh cannabis, cannabis extracts, cannabis topicals and edible cannabis products.
As well, shares of Antibe Therapeutics Inc. (TSXV:ATE) slid 25% to $0.58 as the biopharma company said its lead drug, ATB-346, met the primary endpoint in the Phase 2B dose-ranging, efficacy study to reduce osteoarthritis pain. The Company added that the lowest effective dose is still to be established.
Greenbriar Capital Corp. (TSXV:GRB), meanwhile, reported that it is seeking to obtain a listing on the NASDAQ Global Market Select. The Company is set to construct the 160MWdc/80MWac Montalva solar project in Puerto Rico. Greenbriar Capital stock popped 34% to $3.99 following the announcement.
Finally, Excellon Resources Inc. (TSX:EXN) shares surged 15% to $0.92 after the precious metals junior announced that the Mexican government will allow mining to restart on June 1, 2020. The Company also reported first-quarter revenue that rose to US$6.6 million from $5.2 million during the same period last year.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
HEXO Corp. (TSX:HEXO), a Canadian cannabis stock, gained 9% to $0.93 on Monday after announcing that its Belleville, Ontario manufacturing and processing facility has received a Health Canada license amendment for the sale of dried and fresh cannabis, cannabis extracts, cannabis topicals and edible cannabis products.
, on Monday.){kind=link}